ConductScience.org, home

Paper33101030

Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.

Honrao C and 9 others. Front Pharmacol, 2020. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite. Papers, record 33101030. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33101030

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
PubMed
Journal
Front Pharmacol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2021-05-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Honrao CChandrashekhar
2Ma XXiaoyu
3Kulkarni SShashank
4Joshi VVinit
5Malamas MMichael
6Zvonok AAlexander
7Wood JJodiAnne
8Strand DDavid
9Guo JJJason J
10Makriyannis AAlexandros

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 DA032020NIDA NIH HHSUnited StatesR21DA032020PubMed and NIHNIH RePORTER
R33 DA032020NIDA NIH HHSUnited StatesR21DA032020PubMed and NIHNIH RePORTER
R37 DA003801NIDA NIH HHSUnited StatesR01DA003801PubMed and NIHNIH RePORTER
P01 DA009158NIDA NIH HHSUnited StatesP01DA009158PubMed and NIHNIH RePORTER
R01 DA003801NIDA NIH HHSUnited StatesR01DA003801PubMed and NIHNIH RePORTER
R33DA032020NIHNIH RePORTER
R37DA003801NIHNIH RePORTER

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in33,967,764Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.https://conductscience.org/library/papers/33967764

Source PubMed

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,999,995Adamantyl cannabinoids: a novel class of cannabinergic ligands.J Med Chem2005https://conductscience.org/library/papers/15999995PubMed
215,638,474High-throughput microcoil NMR of compound libraries using zero-dispersion segmented flow analysis.J Comb Chem2005https://conductscience.org/library/papers/15638474PubMed
325,957,385Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.J Anal Toxicol2015https://conductscience.org/library/papers/25957385PubMed
415,698,792Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs.Bioorg Med Chem2005https://conductscience.org/library/papers/15698792PubMed
518,235,504Structural basis for the function and inhibition of an influenza virus proton channel.Nature2008https://conductscience.org/library/papers/18235504PubMed
630,639,103Crystal Structure of the Human Cannabinoid Receptor CB2.Cell2019https://conductscience.org/library/papers/30639103PubMed
725,849,525Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Neurosci Lett2015https://conductscience.org/library/papers/25849525PubMed
819,748,066Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.Best Pract Res Clin Endocrinol Metab2009https://conductscience.org/library/papers/19748066PubMed
926,002,511CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.AAPS J2015https://conductscience.org/library/papers/26002511PubMed
1023,913,126First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry.AAPS J2013https://conductscience.org/library/papers/23913126PubMed
1118,834,150Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites.Anal Chem2008https://conductscience.org/library/papers/18834150PubMed
1226,792,810Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.J Anal Toxicol2016https://conductscience.org/library/papers/26792810PubMed
1315,144,211Microflow NMR: concepts and capabilities.Anal Chem2004https://conductscience.org/library/papers/15144211PubMed
1415,891,249Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.Skinmed2005https://conductscience.org/library/papers/15891249PubMed
1512,672,860Memantine in moderate-to-severe Alzheimer's disease.N Engl J Med2003https://conductscience.org/library/papers/12672860PubMed
1629,790,809Characterization of in vitro and in vivo metabolism of leelamine using liquid chromatography-tandem mass spectrometry.Xenobiotica2019https://conductscience.org/library/papers/29790809PubMed
1718,542,883Microcoil NMR spectroscopy: a novel tool for biological high throughput NMR spectroscopy.Methods Mol Biol2008https://conductscience.org/library/papers/18542883PubMed
1824,028,148Nuclear magnetic resonance at the picomole level of a DNA adduct.Chem Res Toxicol2013https://conductscience.org/library/papers/24028148PubMed
1926,584,231OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.J Chem Theory Comput2016https://conductscience.org/library/papers/26584231PubMed
2028,537,398
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.
J Med Chem2017https://conductscience.org/library/papers/28537398PubMed

See all 48 references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CLINT19,685PubTator's text mininghttps://conductscience.org/library/genes/9685NCBI Gene
CNR21,269PubTator's text mininghttps://conductscience.org/library/genes/1269NCBI Gene
CYP3A41,576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
PPIG9,360PubTator's text mininghttps://conductscience.org/library/genes/9360NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33101030

GET https://conductscience.org/api/papers/v1/33101030/references?page=2